SARS-COV-2

This study tested the Moderna COVID-19 vaccine in over 4,300 healthy teenagers aged 12 to under 18. Researchers checked for side effects and measured how well the vaccine triggered an immune response compared to young adults. The study also looked at a booster dose and an updated…

This study tested updated mRNA COVID-19 vaccines in about 1,800 children aged 6 months to under 6 years. It checked how well the vaccines triggered an immune response and monitored for side effects. The goal was to see if these variant-targeted vaccines are safe and work well for…

This study tested a new DNA vaccine called GLS-5310 to see if it is safe and can protect against COVID-19. Healthy adults aged 19 to 85 received the vaccine or a placebo. Researchers measured side effects and immune responses, including antibodies and T cells.

This study tested a COVID-19 mRNA vaccine (BNT162b2) in 960 healthy Chinese adults aged 18 to 85. Participants received two shots, 21 days apart, and were monitored for about 13 months. The main goal was to check safety and how well the vaccine triggered an immune response. Resul…

This study tested new COVID-19 mRNA booster vaccines in 692 healthy adults who had already received their primary vaccination series. The goal was to see how well the boosters boosted immunity and if they were safe. Participants received either an investigational booster or a con…

This study tested a new vaccine that aims to protect against both COVID-19 and the flu with a single shot. About 932 adults aged 50 to 64 received the vaccine to check its safety and how well it triggers an immune response. The goal is to see if this combined approach is as effec…

This study tested the safety and immune response of several modified mRNA vaccines in 308 healthy adults aged 18 to 75. The vaccines target SARS-CoV-2, seasonal influenza, respiratory syncytial virus, and cytomegalovirus. Researchers monitored side effects and measured antibody l…

This study tested a new combination vaccine (mRNA-1083) that targets both influenza and COVID-19 in a single shot. About 1,320 healthy adults aged 18 to 64 took part. Researchers measured how well the vaccine boosted immunity and monitored for side effects. The goal is to simplif…

This study tested a new combination vaccine that aims to protect against both the flu and COVID-19 with a single shot. Researchers enrolled 1,758 healthy adults to check the vaccine's safety and how well it triggers the immune system. The goal is to simplify annual vaccinations b…

This study checked how well a new test called VitaSIRO solo™ detects COVID-19, flu, and RSV from nasal swabs. Over 1,200 people with respiratory symptoms took part. The test was compared to standard lab tests to see if it is accurate and reliable.

This study tested nearly 950 adults with COVID-19 symptoms to see how well different test methods work. Researchers compared saliva samples and nose swabs, using both a rapid antigen test (results in minutes) and a lab PCR test (results in hours). The goal was to find out which c…

This study tested a new vaccine called S-268019 to see if it could prevent COVID-19. About 9,900 adults who had never had COVID-19 received either the vaccine or a placebo. Researchers tracked how many people got sick with COVID-19 after vaccination to measure the vaccine's effec…

This study tested whether a budesonide nasal spray can improve smell in COVID-19 patients who lost it for at least 30 days. About 120 adults with mild COVID-19 and persistent smell loss took part. The treatment aims to reduce inflammation in the nose and help restore the sense of…

This study tested promising treatments for COVID-19 in adults with mild to moderate symptoms. The goal was to see if these treatments could help people feel better faster and prevent the virus from spreading to others. 92 participants were involved, and the study is now complete.

This study looked at health records from nearly 20 million people in California and Louisiana to see how well different versions of the Pfizer-BioNTech COVID-19 vaccine prevent severe illness, hospitalization, and death. No new participants were enrolled; instead, researchers use…

This study looked at how the COVID-19 pandemic changed healthcare and affected the quality of life of over 5,000 Dutch patients who had surgery or another medical procedure in 2020-2021. Researchers created a survey to capture patients' experiences and linked their answers to nat…

This study looked at 2,484 adults in the Olomouc region to find out how many had antibodies or cellular immunity against the SARS-CoV-2 virus, either from past infection or vaccination. Participants gave blood samples and answered a questionnaire. The goal was to understand the l…

This study enrolled 760 adults who had tested positive for SARS-CoV-2 and recovered. Researchers measured antibodies and immune cells in blood samples over several months to understand how the body remembers the virus. The goal was to improve tests and help design better vaccines…

This study created a global registry to track how COVID-19 impacts kidney function in 500 patients. Researchers aim to understand how often kidney damage occurs and identify who is most at risk. The goal is to gather knowledge that can help improve future care for COVID-19 patien…

This study followed 187 people who had COVID-19 to measure their antibody levels over 24 months. Researchers wanted to see how long antibodies stay in the body and whether they continue to work against the virus. They also looked at how the severity of the initial infection and v…

This study tested whether measuring a protein called MxA in the blood can help doctors decide when to stop antiviral treatment in people with flu or COVID-19. 86 adults took part, and researchers compared those whose treatment was guided by MxA levels to those receiving standard …

This study looked at whether nutritional status affects the risk of death in adults aged 70 and older with COVID-19. Researchers compared death rates between those with good and poor nutrition. The goal was to understand if undernutrition makes older patients more vulnerable to s…

This study compared how often patients on breathing machines developed lung infections. Researchers looked at three groups: people with COVID-19, people with the flu, and people with no viral pneumonia. The goal was to see if COVID-19 increases the chance of getting a ventilator-…

This study followed over 800 healthcare workers and non-healthcare workers for several years to understand how SARS-CoV-2 spreads and who gets sicker. Researchers collected swabs, blood, and saliva samples along with survey data. The goal was to identify risk factors for infectio…

This study looked at 57 adults with mild or no COVID-19 symptoms to understand how their immune system responds to the virus. Researchers measured immune markers and how quickly the virus cleared from the body. The goal was to learn why some people fight off the infection easily,…

This study looked at 120 hospitalized COVID-19 patients with severe breathing problems to understand how their immune systems were reacting. Researchers measured many immune markers in the blood to see if a specific immune pattern could predict who might die. The goal was to find…

This study tested nearly 97,000 people in France for antibodies to see how many had been infected with the COVID-19 virus. Researchers wanted to understand who got infected and how long antibodies last. Participants were already part of long-term health studies, so no new volunte…

This study tested over 1,000 healthcare workers for COVID-19 and tracked their antibody levels over time. The goal was to understand how the virus spreads and how the immune system responds. Participants gave blood samples and nasal swabs to check for current or past infection.